M. Hornung, L. Wesemann
FULL PAPER
solution and refinement. Numerical absorption correction based
on crystal-shape optimization was applied for 1–9 with Stoe’s X-
Red and X-Shape.[37–43] Crystal data are listed in Tables 1 and 2.
[(dppp)Pd(SnB11H11){C(Me)=NH–CMe3}] (7): [(dppp)Pd(Me)Cl]
(56.9 mg, 0.10 mmol) and [Et3NH]2[SnB11H11] (45.3 mg,
0.10 mmol) were dissolved in acetonitrile, stirred for 1 h and tert-
butyl isocyanide (11 µL, 0.10 mmol) was added. Crystals were ob-
tained by slow diffusion of ethyl ether into the acetonitrile solution
(58.6 mg, 67.6%). C33H50B11NP2PdSn (866.77): calcd. C 45.73, H
[cis-(R–NϵC)2PdCl2] [R
=
Me3C, C6H11, 2,6-Me2C6H3,
C6H5CH2]: A suspension of PdCl2 and 2 equiv. of isocyanide in
CH3CN were stirred for 24 h. The solvent was removed in vacuo to
give a solid. The products were characterized by IR spectroscopy.
5.81, N 1.62; found C 45.52, H 5.37, N 1.64. IR (ATR): ν = 1574
˜
[s, ν(CϵN)] cm–1.
[Et3MeN]6[Pd(SnB11H11)4] (1): 28.6 mg (0.10 mmol) of [(COD)-
PdCl2] and 192.2 mg (0.40 mmol) [Et3MeN]2[SnB11H11] were al-
lowed to react in 10 mL of CH3CN. Crystals were obtained by slow
diffusion of ethyl ether into the acetonitrile solution: 137.2 mg of
1, 76% yield.
[(dppf)Pd(SnB11H11){C(Me)=NH–CMe3}] (8): [(dppf)Pd(Me)Cl]
(55.5 mg, 0.10 mmol) and [Bu3NH]2[SnB11H11] (62.1 mg,
0.10 mmol) were dissolved in dichloromethane, stirred for 1 h and
tert-butyl isocyanide (11 µL, 0.10 mmol) was added. Crystals were
obtained by slow diffusion of ethyl ether into the dichloromethane
solution (63.6 mg, 63.1%). C40H52B11FeNP2PdSn (1008.71): calcd.
C 47.63, H 5.20, N 1.39; found C 47.15, H 5.04, N 1.18. IR (ATR):
[Et3NH]2[trans-(C6H5CH2–NϵC)2Pd(SnB11H11)2]
(2):
[cis-
(C6H5CH2–NϵC)2PdCl2] (41.2 mg, 0.10 mmol) and [Et3NH]2-
[SnB11H11] (90.5 mg, 0.20 mmol) were dissolved in acetonitrile. Red
crystals were obtained by slow diffusion of ethyl ether into the
acetonitrile solution (63.1 mg, 60.5% yield). C28H68B22N4PdSn2
(1042.56): calcd. C 32.26, H 6.57, N 5.37; found C 32.52, H 6.62,
ν = 1580 [s, ν(CϵN)] cm–1.
˜
[(dppf)Pd(SnB11H11)(CϵN–C6H11)]
(9):
[(dppf)Pd(Me)Cl]
(55.5 mg, 0.10 mmol) and [Bu3NH]2[SnB11H11] (62.1 mg,
0.10 mmol) were dissolved in dichloromethane and cyclohexyl iso-
cyanide (12 µL, 0.10 mmol) was added. Crystals were obtained by
slow diffusion of ethyl ether into the dichloromethane solution
(31.1 mg, 32.5%). C41H50B11FeNP2PdSn (1018,70): calcd. C 48.34,
H 4.95, N 1.37; found C 48.48, H 4.36, N 1.38.
N 5.53. IR (ATR): ν = 2217 [s, ν(CϵN)] cm–1. NMR spectroscopy:
˜
[Bu3NH]2[trans-(C6H5CH2–NϵC)2Pd(SnB11H11)2]: 1H NMR
(CD2Cl2): δ = 7.17–7.38 (m, 10 H, –C6H5), 2.93 (m, 12 H, –N–
CH2–CH2–), 1.64 (m, 12 H, –CH2–CH2–CH2–), 1.31 (m, 12 H,
–CH2–CH2–CH3), 0.88 (m, 18 H, –CH2–CH3) ppm. 11B{1H}
NMR (CD2Cl2): δ = –9.3 (B12), –14.8 (B2–B11) ppm. 13C{1H}
NMR (CD2Cl2): δ = 205.7 (Pd–CϵN–), 128.5, 126.5 (br., –C6H5),
52.1 (–N–CH2–CH2–), 29.8 (N–CH2–C6H5), 24.7 (–CH2–CH2–
CH2–), 19.3 (–CH2–CH2–CH3), 12.7 (–CH2–CH3) ppm. 119Sn{1H}
NMR (CD2Cl2): δ = –307 ppm.
[Bu3MeN][(dppp)Pd(Me)(SnB11H11)]: [(dppp)PdCl(Me)] (56.9 mg,
0.10 mmol) and [Bu3MeN]2[SnB11H11] (64.9 mg, 0.10 mmol) were
dissolved in dichloromethane and stirred for 1 h. The solution was
removed and the yellow residue was washed with water. The pow-
der was dried in vacuo. (69.3 mg, 70.5%). [Bu3MeN][(dppp)-
Pd(Me)(SnB11H11)]·H2O. C41H72B11NOP2PdSn (1001.03): calcd. C
49.19, H 7.25, N 1.40; found C 48.87, H 7.09, N 1.81. NMR spec-
[Bu3NH]2[trans-(Me3C–NϵC)2Pd(SnB11H11)2] (3): The complex
was prepared in the same way as 2. Instead of acetonitrile dichloro-
methane was used (73.3 mg, 64.1% yield). C34H96B22N4PdSn2
(1142.85): calcd. C 35.73, H 8.47, N 4.90; found C 35.88, H 8.47,
1
troscopy [Bu3NH][Pd(dppp)(Me)(SnB11H11)]: H NMR (CD2Cl2):
δ = 7.16–7.72 (m, 20 H, P–C6H5), 3.01 (m, 6 H, –N–CH2–CH2–),
2.65 (m, 2 H, P–CH2–CH2), 2.45 (m, 2 H, P–CH2–CH2) 2.02 (m,
2 H, P–CH2–CH2–CH2–P), 1.73 (m, 6 H, –CH2–CH2–CH2–), 1.40
(m, 6 H, –CH2–CH2–CH3), 0.89 (m, 9 H, –CH2–CH3), 0.58 [t,
3J(31P1H) = 7 Hz, Pd–CH3] ppm. 11B{1H} NMR (CD2Cl2): δ =
–11.0 (B12), –15.2 (B2–B11) ppm. 13C{1H} NMR (CD2Cl2): δ =
125.6–134.7 (m, P–C6H5), 53.2 (–N–CH2–CH2–), 28.9 (d, P–CH2–
CH2), 28.0 (d, P–CH2–CH2), 25.9 (–CH2–CH2–CH2–), 20.5
(–CH2–CH2–CH3), 19.9 (s, P–CH2–CH2–CH2–P), 13.8 (–CH2–
N 4.81. IR (ATR): ν = 2201 [s, ν(CϵN)] cm–1. 1H NMR (CD Cl ):
˜
2
2
δ = 3.03 (m, 12 H, –N–CH2–CH2–), 1.73 (m, 12 H, –CH2–CH2–
CH2–), 1.55 (m, –C–(CH3)3), 1.39 (m, 12 H, –CH2–CH2–CH3),
0.94 (m, 18 H, –CH2–CH3) ppm. 11B{1H} NMR (CD2Cl2): δ =
–9.4 (B12), –15.0 (B2–B11) ppm. 13C{1H} NMR (CD2Cl2): δ =
125.5 (Pd–CϵN–), 60.8 [–N–C(CH3)], 53.3 (–N–CH2–CH2–), 30.1
[–C(CH3)], 25.9 (–CH2–CH2–CH2–), 20.4 (–CH2–CH2–CH3), 13.9
(–CH2–CH3) ppm. 119Sn{1H} NMR (CD2Cl2): δ = –305 [d,
2J(119Sn-117Sn) = 17106 Hz] ppm.
2
CH3), –1.8 [d, J(31P13C) = 88 Hz, Pd–CH3] ppm. 31P{1H} NMR
(CD2Cl2): δ = 14.2 [d, 2J(31P31P, cis) = 53, 2J(119Sn-31P, trans) =
2
2
2584, J(117Sn-31P, trans) = 2474 Hz], –0.3 [d, J(31P31P, cis) = 53,
2J(119Sn-31P, cis) = 343, 2J(117Sn-31P, cis) = 330 Hz] ppm. 119Sn{1H}
[Et4N]4[(C6H11–NϵC)Pd(SnB11H11)3] (4): The complex was pre-
NMR (CD2Cl2): δ = –281 [d, J(119Sn-31P, trans) = 2673 Hz] ppm.
2
pared in the same way as
2
(85.4 mg, 57.6% yield).
C39H124B33N5PdSn3 (1482.76): calcd. C 31.59, H 8.43, N 4.72;
[Bu3MeN][(dppf)Pd(Me)(SnB11H11)]: [(dppf)PdCl(Me)] (65.6 mg,
0.10 mmol) and [Bu3MeN]2[SnB11H11] (64.9 mg, 0.10 mmol) were
dissolved in dichloromethane and stirred for 1 h. The solution was
removed and the yellow residue was washed with water. The pow-
der was dried in vacuo. (82.1 mg, 73.0%). [Bu3MeN][(dppf)-
Pd(Me)(SnB11H11)]·2H2O. C48H76B11FeNO2P2PdSn (1160.98):
calcd. C 49.66, H 6.60, N 1.21; found C 49.90, H 6.59, N 1.71.
found C 31.32, H 8.46, N 4.57. IR (ATR): ν = 2198 [s, ν(CϵN)]
˜
cm–1.
[Me4N]4[(2,6-Me2C6H3–NϵC)Pd(SnB11H11)3] (5): The complex
was prepared in the same way as 2 (74.6 mg, 59.0% yield). [Et4N]4-
[(2,6-Me2C6H3–NϵC)Pd(SnB11H11)3]·Et2O. C45H132B33N5OPdSn3
(1578.89): calcd. C 34.23, H 8.43, N 4.44; found C 34.60, H 8.11,
1
NMR spectroscopy [Bu3NH][(dppf)Pd(Me)(SnB11H11)]: H NMR
N 4.52. IR (ATR): ν = 2193 [s, ν(CϵN)] cm–1.
˜
(CD2Cl2): δ = 7.16–7.52 (m, 20 H, P–C6H5), 3.72–4.63 (m, 8 H, P–
C5H4), 2.94 (m, 6 H, –N–CH2–CH2–), 1.70 (m, 6 H, –CH2–CH2–
CH2–), 1.40 (m, 6 H, –CH2–CH2–CH3), 0.98 (m, 9 H, –CH2–CH3),
0.67 (m, Pd–CH3) ppm. 11B{1H} NMR (CD2Cl2): δ = –15.4 (B2–
B11) ppm. 13C{1H} NMR (CD2Cl2): δ = 125.6–134.3 (m, P–C6H5),
72.5–76.5 (m, P–C5H4), 53.5 (–N–CH2–CH2–), 26.5 (–CH2–CH2–
[(dppe)Pd(SnB11H11){C(Me)=NH-2,6-C6H3Me2}] (6): [(dppe)Pd-
(Me)Cl] (55.5 mg, 0.10 mmol) and [Et3NH]2[SnB11H11] (45.3 mg,
0.10 mmol) were dissolved in acetonitrile, stirred for 1 h and 2,6-
dimethylphenyl isocyanide (13.1 mg, 0.10 mmol) was added. Crys-
tals were obtained by slow diffusion of ethyl ether into the acetoni-
trile solution (54.5 mg, 60.5%). C36H48B11NP2PdSn (900.78): CH2–), 20.5 (–CH2–CH2–CH3), 13.9 (–CH2–CH3), 0.7 [d,
calcd. C 48.00, H 5.37, N 1.55; found C 48.61, H 4.94, N 0.48. IR
2J(31P13C) = 84 Hz, Pd–CH3] ppm. 31P{1H} NMR (CD2Cl2): δ =
2
2
2
(ATR): ν = 1585 [s, ν(CϵN)] cm–1.
31.5 [d, J(31P31P, cis) = 34, J(119Sn–31P, trans) = 2719, J(117Sn–
˜
2954
www.eurjic.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2010, 2949–2955